Publications

Publications Search

Search for publications by author
Search for publications by abstract keyword(s)

Search results

52 items matching your search terms.
OpenAccess publication MECP2 is a frequently amplified oncogene with a novel epigenetic mechanism that mimics the role of activated RAS in malignancy
Neupane, M.; Clark, A. P.; Landini, S.; Birkbak, N. J.; Eklund, A. C.; Lim, E.; Culhane, A. C.; Barry, W. T.; Schumacher, S. E.; Beroukhim, R.; Szallasi, Z.; Vidal, M.; Hill, D. E.; Silver, D. P.;
Cancer Discovery 6 (1) :45-58, 2016 10.1158/2159-8290.CD-15-0341
OpenAccess publication Clinical Overview of MDM2/X-Targeted Therapies
Burgess, A.; Chia, K. M.; Haupt, S.; Thomas, D.; Haupt, Y.; Lim, E.;
Frontiers in Oncology 6 :7, 2016
Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
Wee, Z. N. ; Yatim, S. M. ; Kohlabauer, V. K. ; Feng, M. ; Goh, J. Y. ; Bao, Y. ; Lee, P. L. ; Zhang, S. ; Wang, P. P. ; Lim, E. ; Tam, W. L. ; Cai, Y. ; Ditzel, H. J. ; Hoon, D. S. ; Tan, E. Y. ; Yu, Q.;
Nature Communications 6 :10054, 2015
OpenAccess publication IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel
Wee, Z. N.; Yatim, S. M.; Kohlbauer, V. K.; Feng, M.; Goh, J. Y.; Yi, B.; Lee, P. L.; Zhang, S.; Wang, P. P.; Lim, E.; Tam, W. L.; Cai, Y.; Ditzel, H. J.; Hoon, D. S.; Tan, E. Y.; Yu, Q.;
Nature Communications 6 :8746, 2015